MIRA Pharmaceuticals (NASDAQ:MIRA) | WebDisclosure

Switch to English

9805	Sociétés
196647	Mots-clés
127661	Articles
104550	Communiqués

Accueil
Sociétés
MIRA Pharmaceuticals

COMMUNIQUÉ DE PRESSE

publié le 22/07/2024 à 14:00, il y a 1 année 6 mois

MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance
MIRA Pharmaceuticals reveals new promising preclinical data for Ketamir-2, a novel oral ketamine analog, indicating potential advantages for treating neurological and neuropsychiatric disorders

Preclinical Study Neurological Disorders MIRA Pharmaceuticals Neuropsychiatric Disorders Ketamir-2
BRÈVE

publiée le 15/07/2024 à 13:05, il y a 1 année 6 mois

Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC

Pharmaceuticals Preclinical Studies MIRA-55 Anxiety Treatment THC Comparison
BRÈVE

publiée le 15/07/2024 à 13:05, il y a 1 année 6 mois

Mira Pharmaceuticals annonce des résultats prometteurs pour MIRA-55 dans plusieurs tests précliniques par rapport au THC

Médicaments Etudes Précliniques MIRA-55 Traitement De L'anxiété Comparaison Du THC
COMMUNIQUÉ DE PRESSE

publié le 15/07/2024 à 13:00, il y a 1 année 6 mois

Mira Pharmaceuticals Announces Promising Results for MIRA-55 in Multiple Preclinical Tests Compared to THC
MIRA Pharmaceuticals, Inc. confirms promising findings on new oral pharmaceutical marijuana analog, MIRA-55, as a potential treatment for neurological and neuropsychiatric disorders. Comparison to THC shows enhanced efficacy and consistent anxiolytic effects

Neurological Disorders Preclinical Studies MIRA-55 MIRA Pharmaceuticals Neuropsychiatric Disorders

Les Echos

Publié le 04/02/2026 à 18:04, il y a 11 heures 47 minutes

Capital et droits de vote au 31 janvier 2026
Publié le 04/02/2026 à 18:04, il y a 11 heures 47 minutes

Total number of voting rights and shares making up the share capital at January 31, 2026
Publié le 04/02/2026 à 17:45, il y a 12 heures 6 minutes

Information concerning the total number of voting rights and shares 2026 01 31
Publié le 04/02/2026 à 17:45, il y a 12 heures 6 minutes

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Publié le 04/02/2026 à 17:45, il y a 12 heures 6 minutes

Janvier 2026

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 05/02/2026 à 01:35, il y a 4 heures 16 minutes

Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Publié le 05/02/2026 à 00:00, il y a 5 heures 51 minutes

Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Publié le 04/02/2026 à 22:25, il y a 7 heures 26 minutes

55 North Mining Announces Flow-Through Financing
Publié le 04/02/2026 à 18:00, il y a 11 heures 51 minutes

Lithium South AGSM Update
Publié le 04/02/2026 à 16:15, il y a 13 heures 36 minutes

Trans Canada Gold Enters into an Option Agreement with Bear Mountain Gold Mines to Acquire a 60% Interest in the Harrison Lake District Scale Gold Property, with $10.0 Million Dollars in Prior Exploration Expenditures

Voir tout ACCESSWIRE

EQS Group

Publié le 04/02/2026 à 20:54, il y a 8 heures 57 minutes

Elmos Semiconductor SE is planning to distribute 36 million Euro to shareholders for the fiscal year 2025
Publié le 04/02/2026 à 20:36, il y a 9 heures 15 minutes

EQS-Adhoc: Elmos Semiconductor SE approves share buyback program via the stock exchange of 10 million Euro and dividend proposal of 1.50 Euro per share for fiscal year 2025
Publié le 04/02/2026 à 20:00, il y a 9 heures 51 minutes

Belgium's Ingmar De Vos elected to Executive Board of International Olympic Committee
Publié le 04/02/2026 à 18:55, il y a 10 heures 56 minutes

Funding Circle Holdings plc: POS-Transaction in Own Shares
Publié le 04/02/2026 à 18:40, il y a 11 heures 11 minutes

Robin Zeng: Unlocking the Sustainable Energy Era with Zero-Carbon Technology